Rani Therapeutics Raises $69 Million Series E To Advance Clinical Trials And Manufacturing Of Robotic Pill

SAN JOSE, Calif., Dec. 10, 2020 -- (Healthcare Sales & Marketing Network) -- Rani Therapeutics, a clinical-stage biopharmaceutical company and developer of the RaniPill™ robotic pill, today announced that it has raised $69 million in a Series E financing,... Biopharmaceuticals, Drug Delivery, Venture Capital Rani Therapeutics, RaniPill, robotic pill
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news